Isis expands patent portfolio related to bicyclic nucleic acids (BNAs) and antisense oligomers containing BNAs
Clients Isis Pharmaceuticals, Inc.
Jones Day represents Isis Pharmaceuticals, Inc. with the management and development of a patent portfolio related to bicyclic nucleic acids (BNAs) and antisense oligomers containing BNAs.